LinkedIn Profile

Access Springleaf Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:springleaftherapeutics 2426585 Nov 12th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 12th, 2019 04:45PM Nov 12th, 2019 04:45PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 11th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 11th, 2019 03:07PM Nov 11th, 2019 03:07PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 10th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 10th, 2019 05:34PM Nov 10th, 2019 05:34PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 9th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 9th, 2019 06:03PM Nov 9th, 2019 06:03PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 8th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 8th, 2019 12:53PM Nov 8th, 2019 12:53PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 7th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 7th, 2019 01:37PM Nov 7th, 2019 01:37PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 6th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 6th, 2019 05:42PM Nov 6th, 2019 05:42PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 5th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 5th, 2019 01:49PM Nov 5th, 2019 01:49PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 4th, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 3rd, 2019 07:49PM Nov 4th, 2019 04:35PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Nov 2nd, 2019 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Nov 2nd, 2019 06:14PM Nov 2nd, 2019 06:14PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.